Short answer
SANUWAVE Health, Inc. (SNWV) filed its Q1 2026 10-Q quarterly report on May 12, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $10M (up 3.0% year over year) with net income of −$1M.
Q1 2026 key financials · XBRL
- Revenue
- $10M
- +3.0% YoY
- Net income
- −$1M
- +74.6% YoY
- Operating margin
- -11.7%
- Gross margin
- 77.3%
- EPS (diluted)
- −$0.17
- +74.2% YoY
Source: XBRL data from the SANUWAVE Health, Inc. (SNWV) Q1 2026 10-Q on SEC EDGAR. USD.
SANUWAVE Health, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $9.6M, up 3% YoY from $9.3M, driven by UltraMIST disposables quantity growth of 22%
- Gross margin 77% vs 79% YoY, pressured by lower UltraMIST system and applicator pricing
- UltraMIST 100% of revenue; systems volume down 1% and disposables pricing down 6%
- Cash $10.8M; operating cash flow $0.4M vs $(1.5)M YoY, with $1.4M term-loan principal payments
- Outlook: sufficient resources for at least 12 months; elevated inflation may pressure compensation, leasing, and R&D costs
Risk Factors
- Unregistered securities issuance: 4,000 common shares issued to Big Vision Ventures LLC for consulting services
- Securities-law compliance: Reliance on Securities Act Section 4(a)(2) exemption from registration
- Governance disclosure: No director or officer adopted or terminated Rule 10b5-1 plans during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SANUWAVE Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.